Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy

Paul J. Tuite, H. Brent Clark, Catherine Bergeron, Matthew Bower, Peter St George-Hyslop, Vesselina Mateva, John Anderson, David S Knopman

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: Corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) are neurodegenerative tauopathies. Sporadic and familial cases of PSP and CBD have been noted, but both have not been reported in a single family. Objective: To describe the clinical, oculomotor, balance, functional imaging, histopathologic, and genetic studies in a family with CBD and PSP. Design: A report of the clinical and pathological features in a familial tauopathy. Setting: University of Minnesota. Patients: We evaluated 2 siblings and clinically assessed 20 additional family members. Main Outcome Measures: Demonstration of salient features in deceased and living family members. Results: Histopathologically confirmed CBD in one sibling and PSP in another deceased sibling were demonstrated; both had clinical features of corticobasal syndrome. In addition, 3 siblings had probable PSP by clinical criteria. Genetic studies of 4 affected family members demonstrated the H1/H1 haplotype but did not reveal pathogenic tau mutations. The family history revealed consanguinity. Conclusions: This is the first report, to our knowledge, of CBD and PSP in 2 individuals in a single family who presented with corticobasal syndrome and had other affected siblings with clinical PSP. Despite clinical and pathologic heterogeneity, a unifying genetic etiology appears likely in this familial tauopathy.

Original languageEnglish (US)
Pages (from-to)1453-1457
Number of pages5
JournalArchives of Neurology
Volume62
Issue number9
DOIs
StatePublished - Sep 2005

Fingerprint

Tauopathies
Progressive Supranuclear Palsy
Siblings
Consanguinity
Familial progressive supranuclear palsy
Degeneration
Familial
Haplotypes
Outcome Assessment (Health Care)
Mutation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy. / Tuite, Paul J.; Clark, H. Brent; Bergeron, Catherine; Bower, Matthew; St George-Hyslop, Peter; Mateva, Vesselina; Anderson, John; Knopman, David S.

In: Archives of Neurology, Vol. 62, No. 9, 09.2005, p. 1453-1457.

Research output: Contribution to journalArticle

Tuite, PJ, Clark, HB, Bergeron, C, Bower, M, St George-Hyslop, P, Mateva, V, Anderson, J & Knopman, DS 2005, 'Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy', Archives of Neurology, vol. 62, no. 9, pp. 1453-1457. https://doi.org/10.1001/archneur.62.9.1453
Tuite, Paul J. ; Clark, H. Brent ; Bergeron, Catherine ; Bower, Matthew ; St George-Hyslop, Peter ; Mateva, Vesselina ; Anderson, John ; Knopman, David S. / Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy. In: Archives of Neurology. 2005 ; Vol. 62, No. 9. pp. 1453-1457.
@article{4a7d4fffdade49c6803285327c5d413b,
title = "Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy",
abstract = "Background: Corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) are neurodegenerative tauopathies. Sporadic and familial cases of PSP and CBD have been noted, but both have not been reported in a single family. Objective: To describe the clinical, oculomotor, balance, functional imaging, histopathologic, and genetic studies in a family with CBD and PSP. Design: A report of the clinical and pathological features in a familial tauopathy. Setting: University of Minnesota. Patients: We evaluated 2 siblings and clinically assessed 20 additional family members. Main Outcome Measures: Demonstration of salient features in deceased and living family members. Results: Histopathologically confirmed CBD in one sibling and PSP in another deceased sibling were demonstrated; both had clinical features of corticobasal syndrome. In addition, 3 siblings had probable PSP by clinical criteria. Genetic studies of 4 affected family members demonstrated the H1/H1 haplotype but did not reveal pathogenic tau mutations. The family history revealed consanguinity. Conclusions: This is the first report, to our knowledge, of CBD and PSP in 2 individuals in a single family who presented with corticobasal syndrome and had other affected siblings with clinical PSP. Despite clinical and pathologic heterogeneity, a unifying genetic etiology appears likely in this familial tauopathy.",
author = "Tuite, {Paul J.} and Clark, {H. Brent} and Catherine Bergeron and Matthew Bower and {St George-Hyslop}, Peter and Vesselina Mateva and John Anderson and Knopman, {David S}",
year = "2005",
month = "9",
doi = "10.1001/archneur.62.9.1453",
language = "English (US)",
volume = "62",
pages = "1453--1457",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy

AU - Tuite, Paul J.

AU - Clark, H. Brent

AU - Bergeron, Catherine

AU - Bower, Matthew

AU - St George-Hyslop, Peter

AU - Mateva, Vesselina

AU - Anderson, John

AU - Knopman, David S

PY - 2005/9

Y1 - 2005/9

N2 - Background: Corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) are neurodegenerative tauopathies. Sporadic and familial cases of PSP and CBD have been noted, but both have not been reported in a single family. Objective: To describe the clinical, oculomotor, balance, functional imaging, histopathologic, and genetic studies in a family with CBD and PSP. Design: A report of the clinical and pathological features in a familial tauopathy. Setting: University of Minnesota. Patients: We evaluated 2 siblings and clinically assessed 20 additional family members. Main Outcome Measures: Demonstration of salient features in deceased and living family members. Results: Histopathologically confirmed CBD in one sibling and PSP in another deceased sibling were demonstrated; both had clinical features of corticobasal syndrome. In addition, 3 siblings had probable PSP by clinical criteria. Genetic studies of 4 affected family members demonstrated the H1/H1 haplotype but did not reveal pathogenic tau mutations. The family history revealed consanguinity. Conclusions: This is the first report, to our knowledge, of CBD and PSP in 2 individuals in a single family who presented with corticobasal syndrome and had other affected siblings with clinical PSP. Despite clinical and pathologic heterogeneity, a unifying genetic etiology appears likely in this familial tauopathy.

AB - Background: Corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) are neurodegenerative tauopathies. Sporadic and familial cases of PSP and CBD have been noted, but both have not been reported in a single family. Objective: To describe the clinical, oculomotor, balance, functional imaging, histopathologic, and genetic studies in a family with CBD and PSP. Design: A report of the clinical and pathological features in a familial tauopathy. Setting: University of Minnesota. Patients: We evaluated 2 siblings and clinically assessed 20 additional family members. Main Outcome Measures: Demonstration of salient features in deceased and living family members. Results: Histopathologically confirmed CBD in one sibling and PSP in another deceased sibling were demonstrated; both had clinical features of corticobasal syndrome. In addition, 3 siblings had probable PSP by clinical criteria. Genetic studies of 4 affected family members demonstrated the H1/H1 haplotype but did not reveal pathogenic tau mutations. The family history revealed consanguinity. Conclusions: This is the first report, to our knowledge, of CBD and PSP in 2 individuals in a single family who presented with corticobasal syndrome and had other affected siblings with clinical PSP. Despite clinical and pathologic heterogeneity, a unifying genetic etiology appears likely in this familial tauopathy.

UR - http://www.scopus.com/inward/record.url?scp=25144500987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25144500987&partnerID=8YFLogxK

U2 - 10.1001/archneur.62.9.1453

DO - 10.1001/archneur.62.9.1453

M3 - Article

C2 - 16157754

AN - SCOPUS:25144500987

VL - 62

SP - 1453

EP - 1457

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 9

ER -